Over a minimal 10-year follow-up Vlaminck et al. retained a revision rate of 26% (34 of 133) stressing the importance of eosinophilic mucin presence on asthma development or aggravation and nasal polyp recurrence (56). This evidence concerns the gene MUC5AC and asthma.